Apollo Hospitals Enterprise on Friday announced its Q4FY25 earnings where the company reported a net profit growth of 53.5% to Rs 390 crore versus Rs 254 crore in the year ago period. The profit is attributable to the owners of the company and has beaten Street's estimates of Rs 374 crore.
The company's board recommended a final dividend of Rs 10 equity share for FY2024-25.
The board has fixed the record date on August 19, 2025 for the purpose of determining the names of the eligible shareholders for the final dividend.
The revenue from operations was reported at Rs 5,592 crore which was a 13% uptick over Rs 4,944 crore reported in the corresponding period of the previous financial year.
Company' Profit After Tax (PAT) increased 5% on a sequential basis versus 372 crore reported in Q3FY25 while the revenue from operations was marginally up by 1.2% over versus Rs 5,527 crore reported in the October-December quarter of FY25.
Apollo Hospitals incurred expenses of Rs 5,148 crore in the quarter under review versus Rs 5,060 crore in Q3FY25 and Rs 4,612 crore in Q4FY24. The expenses were made under the heads like cost of materials consumed, Changes In Inventories of stock-In-trade, employee benefits expense and finance cost.
Segment revenue
The company's revenue comes from healthcare services, retail health & diagnostics and digital health & pharmacy distribution.
- Healthcare services: Q4FY25 revenue stood at Rs 2,843 crore versus Rs 2,803 crore in Q3FY25 and Rs 2,579 crore in Q4FY24.
- Retail Health & Diagnostics: Q4FY25 revenue stood at Rs 394 crore versus Rs 390 crore in Q3FY25 and Rs 354 crore in Q4FY24.
- Digital health & pharmacy distribution: Q4FY25 revenue stood at Rs 2,376 versus Rs 2,352 crore in Q3FY25 and Rs 2,027 crore in Q4FY24.
The company also announced significant expansion in Bengaluru in the Sarjapur micro-market through the addition of 700 beds in 2 stages, to establish a dominant presence in the South-Eastern part of the city with large addressable market.
The company's board recommended a final dividend of Rs 10 equity share for FY2024-25.
The board has fixed the record date on August 19, 2025 for the purpose of determining the names of the eligible shareholders for the final dividend.
The revenue from operations was reported at Rs 5,592 crore which was a 13% uptick over Rs 4,944 crore reported in the corresponding period of the previous financial year.
Company' Profit After Tax (PAT) increased 5% on a sequential basis versus 372 crore reported in Q3FY25 while the revenue from operations was marginally up by 1.2% over versus Rs 5,527 crore reported in the October-December quarter of FY25.
Apollo Hospitals incurred expenses of Rs 5,148 crore in the quarter under review versus Rs 5,060 crore in Q3FY25 and Rs 4,612 crore in Q4FY24. The expenses were made under the heads like cost of materials consumed, Changes In Inventories of stock-In-trade, employee benefits expense and finance cost.
Segment revenue
The company's revenue comes from healthcare services, retail health & diagnostics and digital health & pharmacy distribution.
- Healthcare services: Q4FY25 revenue stood at Rs 2,843 crore versus Rs 2,803 crore in Q3FY25 and Rs 2,579 crore in Q4FY24.
- Retail Health & Diagnostics: Q4FY25 revenue stood at Rs 394 crore versus Rs 390 crore in Q3FY25 and Rs 354 crore in Q4FY24.
- Digital health & pharmacy distribution: Q4FY25 revenue stood at Rs 2,376 versus Rs 2,352 crore in Q3FY25 and Rs 2,027 crore in Q4FY24.
The company also announced significant expansion in Bengaluru in the Sarjapur micro-market through the addition of 700 beds in 2 stages, to establish a dominant presence in the South-Eastern part of the city with large addressable market.
You may also like
Mumbai Cyber Fraud: Transport Businessman Duped Of ₹2.53 Crore In Fake FYERS Trading App Scam; Case Registered
FPJ Impact: BMC's Coastal Road Department Orders L&T To Fill Hazardous Rainwater-Filled Trench At Breach Candy
The price of pride
Pahalgam Terror Attack: Jammu & Kashmir Tourism Devastated As 26 Tourists Killed; CM Omar Abdullah Pushes For Revival Strategy
Bombay HC Denies Pre-Arrest Bail To Real Estate Agent In ₹82 Lakh BMC Bribe Cheating Case
